Cite

    Romero, I. et al. (2019). Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer. Anti-cancer drugs. 30 (6), p. . [Online].